You are here

An intravenous injection of a talc-containing drug

Document

Fibrosing interstitial lung disease - An intravenous injection of a talc-containing drug Factor

Last reviewed for CCPS 16 December 2009.

Preliminary questions [40657]

40679 there is some evidence that intravenous injection of a talc-containing drug may be a factor in the development or worsening of the condition under consideration.

41042 the veteran has received an intravenous injection of a talc-containing drug intended for oral use at some time.

41043the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and VEA service for fibrosing interstitial lung disease.

41044the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and VEA service for the clinical onset of fibrosing interstitial lung disease.

41046the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and operational service for the clinical onset of fibrosing interstitial lung disease.

or

41047the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and eligible service for the clinical onset of fibrosing interstitial lung disease.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

41045the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and VEA service for the clinical worsening of fibrosing interstitial lung disease.

41048the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and operational service for the clinical worsening of fibrosing interstitial lung disease.

or

41049the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and eligible service for the clinical worsening of fibrosing interstitial lung disease.

Clinical onset and operational service [41046]

41050

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years.

41052

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years within the ten years before the clinical onset of fibrosing interstitial lung disease.

41056

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years within the ten years before the clinical onset of fibrosing interstitial lung disease as a causal result of operational service.

41060

the intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years within the ten years before the clinical onset of fibrosing interstitial lung disease, as a causal result of operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

Clinical onset and eligible service [41047]

41051

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years.

41053

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years within the ten years before the clinical onset of fibrosing interstitial lung disease.

41057

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years within the ten years before the clinical onset of fibrosing interstitial lung disease as a causal result of eligible service.

41061

the intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years within the ten years before the clinical onset of fibrosing interstitial lung disease, as a causal result of eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.

Clinical worsening and operational service [41048]

41050

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years.

41054

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years after the clinical onset and within the ten years before the clinical worsening of fibrosing interstitial lung disease.

41058

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years after the clinical onset and within the ten years before the clinical worsening of fibrosing interstitial lung disease as a causal result of operational service.

41062

the intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years within the ten years before the clinical worsening of fibrosing interstitial lung disease, as a causal result of operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

Clinical worsening and eligible service [41049]

41051

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years.

41055

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years after the clinical onset and within the ten years before the clinical worsening of fibrosing interstitial lung disease.

41059

the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years after the clinical onset and within the ten years before the clinical worsening of fibrosing interstitial lung disease as a causal result of eligible service.

41063

the intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years within the ten years before the clinical worsening of fibrosing interstitial lung disease, as a causal result of eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.